Johnson & Johnson Shareholders' Equity
Johnson & Johnson (JNJ) had Shareholders' Equity of $84.97 billion as of 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-23
- 2026-06-28: Stockholders' Equity Attributable to Parent $84.97B.
- 2026-03-29: Stockholders' Equity Attributable to Parent $81.19B.
- 2025-12-28: Stockholders' Equity Attributable to Parent $81.54B.
- 2025-09-28: Stockholders' Equity Attributable to Parent $79.28B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-28 | $84.97B 10-Q · filed 2026-07-23 |
| 2026-03-29 | $81.19B 10-Q · filed 2026-04-22 |
| 2025-12-28 | $81.54B 10-Q · filed 2026-07-23 |
| 2025-09-28 | $79.28B 10-Q · filed 2025-10-22 |
| 2025-06-29 | $78.47B 10-Q · filed 2025-07-24 |
| 2025-03-30 | $78.11B 10-Q · filed 2025-04-23 |
| 2024-12-29 | $71.49B 10-Q · filed 2025-10-22 |
| 2024-09-29 | $70.16B 10-Q · filed 2024-10-23 |
| 2024-06-30 | $71.54B 10-Q · filed 2024-07-25 |
| 2024-03-31 | $70.02B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $68.77B 10-Q · filed 2024-10-23 |
| 2023-10-01 | $71.23B 10-Q · filed 2023-10-27 |
| 2023-07-02 | $75.15B 10-Q · filed 2023-07-31 |
| 2023-01-01 | $76.80B 10-Q · filed 2023-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |